I agree that this site is using cookies. You can find further informations here.
X
Otterson, Gregory A.
224  results:
Search for persons X
?
1

A plain language summary of the PHAROS study: the combinati..:

Riely, Gregory J ; Smit, Egbert F ; Ahn, Myung-Ju...
Future Oncology.  20 (2024)  16 - p. 1047-1055 , 2024
Link: https://doi.org/10.2217/..
 
?
2

A Phase 2 Trial of Primary Tumor Stereotactic Body Radiatio..:

Williams, Terence M. ; Miller, Eric ; Welliver, Meng...
International Journal of Radiation Oncology*Biology*Physics.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

Association of medical comorbidities and cardiovascular dis..:

Johns, Andrew C. ; Yang, Mike ; Wei, Lai...
Cancer Immunology, Immunotherapy.  72 (2023)  7 - p. 2005-2013 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Emerging therapeutic strategies for enhancing sensitivity a..:

Villaruz, Liza C. ; Blumenschein Jr., George R. ; Otterson, Gregory A..
Cancer.  129 (2023)  9 - p. 1319-1350 , 2023
Link: https://doi.org/10.1002/..
 
?
5

Reversible cardiomyopathy in a patient with chronic myelomo..:

Sheel, Ankur ; Bae, Junu ; Asada, Ashlee...
Cardio-Oncology.  9 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
6

Risk Factors for Immune Checkpoint Inhibitor Immunotherapy ..:

Johns, Andrew C ; Yang, Mike ; Wei, Lai...
The Oncologist.  28 (2023)  8 - p. e625-e632 , 2023
Link: https://doi.org/10.1093/..
 
?
7

A cancer disparities curriculum in a hematology/oncology fe..:

Husain, Marium ; Faisal, Muhammad Salman ; Quiroga, Dionisia...
BMC Medical Education.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
8

Mean platelet volume, thrombocytosis, and survival in non-s..:

Li, Mingjia ; Zhao, Songzhu ; Lopez, Gabrielle...
Cancer Immunology, Immunotherapy.  , 2023
Link: https://doi.org/10.1007/..
 
?
9

A Case of Mediastinal Carcinosarcoma With Beta-HCG Producti..:

Shaker, Nada ; Amadi, Chiemezie C. ; Welliver, Meng...
International Journal of Surgical Pathology.  31 (2023)  8 - p. 1598-1604 , 2023
Link: https://doi.org/10.1177/..
 
?
10

Safety of First-Line Nivolumab Plus Ipilimumab in Patients ..:

Paz-Ares, Luis G. ; Ciuleanu, Tudor-Eliade ; Pluzanski, Adam...
Journal of Thoracic Oncology.  18 (2023)  1 - p. 79-92 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Correction: Association between pre‑treatment chest imaging..:

Wong, Alex ; Riley, Maria ; Zhao, Songzhu...
Cancer Immunology, Immunotherapy.  72 (2023)  6 - p. 1737-1737 , 2023
Link: https://doi.org/10.1007/..
 
?
12

Association between pre-treatment chest imaging and pulmona..:

Wong, Alex ; Riley, Maria ; Zhao, Songzhu...
Cancer Immunology, Immunotherapy.  72 (2023)  6 - p. 1727-1735 , 2023
Link: https://doi.org/10.1007/..
 
?
13

First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Y..:

Paz-Ares, Luis G. ; Ramalingam, Suresh S. ; Ciuleanu, Tudor-Eliade...
Journal of Thoracic Oncology.  17 (2022)  2 - p. 289-308 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion..:

Drilon, Alexander ; Chiu, Chao-Hua ; Fan, Yun...
JTO Clinical and Research Reports.  3 (2022)  6 - p. 100332 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Immune checkpoint inhibitor-induced hepatitis injury: risk ..:

Miah, Abdul ; Tinoco, Gabriel ; Zhao, Songzhu...
Journal of Cancer Research and Clinical Oncology.  149 (2022)  5 - p. 2235-2242 , 2022
Link: https://doi.org/10.1007/..
 
1-15